Tag: quizartinib FDA approval

Home / quizartinib FDA approval

Categories

Quizartinib is approved by the FDA for newly diagnosed acute myeloid leukemia

August 2023: The treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) that is FLT3 internal tandem duplication (ITD)-positive, as detected by an FDA-approved test, with stan...
quizartinib-fda-approval

Scan the code